E. Cakmak Et Al. , "Prognostic Significance of P53, Bcl-2, and Fas Expression in Patients with Primary Gastrointestinal Diffuse Large B-Cell Lymphoma," ERCIYES MEDICAL JOURNAL , vol.37, no.3, pp.102-105, 2015
Cakmak, E. Et Al. 2015. Prognostic Significance of P53, Bcl-2, and Fas Expression in Patients with Primary Gastrointestinal Diffuse Large B-Cell Lymphoma. ERCIYES MEDICAL JOURNAL , vol.37, no.3 , 102-105.
Cakmak, E., Sari, I., CANÖZ, Ö., ESER, B., Altuntas, F., ÇETİN, M., ... ÜNAL, A.(2015). Prognostic Significance of P53, Bcl-2, and Fas Expression in Patients with Primary Gastrointestinal Diffuse Large B-Cell Lymphoma. ERCIYES MEDICAL JOURNAL , vol.37, no.3, 102-105.
Cakmak, Erol Et Al. "Prognostic Significance of P53, Bcl-2, and Fas Expression in Patients with Primary Gastrointestinal Diffuse Large B-Cell Lymphoma," ERCIYES MEDICAL JOURNAL , vol.37, no.3, 102-105, 2015
Cakmak, Erol Et Al. "Prognostic Significance of P53, Bcl-2, and Fas Expression in Patients with Primary Gastrointestinal Diffuse Large B-Cell Lymphoma." ERCIYES MEDICAL JOURNAL , vol.37, no.3, pp.102-105, 2015
Cakmak, E. Et Al. (2015) . "Prognostic Significance of P53, Bcl-2, and Fas Expression in Patients with Primary Gastrointestinal Diffuse Large B-Cell Lymphoma." ERCIYES MEDICAL JOURNAL , vol.37, no.3, pp.102-105.
@article{article, author={Erol ÇAKMAK Et Al. }, title={Prognostic Significance of P53, Bcl-2, and Fas Expression in Patients with Primary Gastrointestinal Diffuse Large B-Cell Lymphoma}, journal={ERCIYES MEDICAL JOURNAL}, year=2015, pages={102-105} }